According to UK drug regulators, the number of deaths in the UK has increased to 19 after a blood clot developed after AstraZeneca’s jab vaccination.
However, the Medicines and Healthcare Products Regulatory Agency (MHRA) argued that the benefits of vaccination “continue to outweigh the risks.”
Also Said “Available evidence does not suggest that intravenous thrombosis (venous thromboembolism) is caused by the COVID-19 vaccine AstraZeneca.”
By March 31 79 reports Regulators said the number of cases of blood clotting after the use of the AstraZeneca CCP (Chinese Communist Party) virus vaccine was accepted.
Of the 79 cases, 44 were cases of intracerebral thrombosis known as cerebral sinus thrombosis (CVST), and 35 cases occurred in other major veins.
Cases occurred in 51 women and 28 men between the ages of 18 and 79. MHRA said the high proportion of affected women may be partly explained by the fact that more women than men are vaccinated.
Of the 79 cases, 19 (13 females and 6 males) died. Eleven of them were under the age of 50, and three of them were under the age of 30.
Of these 19 cases, 14 were blood clots in the brain and 5 were blood clots in other major veins.
According to MHRA, all 79 cases occurred after the first of the two recommended vaccinations.
Regulators said last week that the number of deaths from blood clots was seven by March 24.
“This risk, based on the report up to March 31, is slightly higher than the risk calculated from the reports published by March 24,” MHRA said.
In the UK, 20.2 million doses of AstraZeneca vaccine have been given, and the overall risk of blood clots is about 4 in 1 million.
Dr. June Raine, CEO of MHRA, said no link has been established between blood clots and vaccination.
“Our thorough and careful review, along with the critical evaluation of leading independent scientists, provides evidence that both vaccines have more intravenous thrombi than expected without vaccination. It shows that there isn’t, “she said.
Also on Wednesday, the European Medicines Agency, the European Union’s drug regulator, said there was a “potential link” between the AstraZeneca vaccine and the “very rare” blood clot, but vaccination. Encouraged that the benefits outweigh the risks.
Jack Phillips contributed to this report.